SoloHealth, which operates interactive screening kiosks in retail pharmacy locations, has received approval from the U.S. Food and Drug Administration for its new SoloHealth Station, which provides advertising opportunities in addition to its consumer health functions.
Before granting the SoloHealth Station approval, the FDA studied the potential applications for interactive kiosks, including education, self-diagnosis, dispensing drugs for certain chronic conditions, and recommending healthcare providers from local and national databases, all as part of a larger effort to improve access to pharmacy services and healthcare. In 2010 SoloHealth received a $1.2 million grant from the National Institute of to study these needs and develop the kiosk format.
SoloHealth expects to have thousands of SoloHealth Stations active in retail pharmacies across the U.S. by the end of the year, with key strategic alliances to be announced in the next several months. The company will eventually replace the existing SoloHealth network, composed of the company’s first-generation EyeSite Vision kiosks.
The SoloHealth kiosks offer DOOH advertising opportunities in coordination with Internet, mobile and social media.